课题基金 / 基金详情

Mechanisms of immune modulation by human cytomegalovirus during the latent phase of infection

Mechanisms of immune modulation by human cytomegalovirus during the latent phase of infection
人巨细胞病毒感染潜伏期的免疫调节机制
批准号:
nhmrc : 301942
负责人:
A/Pr Allison Abendroth
金额:
$11.04万
依托单位:
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-01-01 至 2004-12-31

项目摘要

项目成果

A/Pr Allison Abendroth的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (CMV) is a herpesvirus which infects a majority of the population. CMV is a significant cause of serious, life-threatening disease in neonates and in people who are immunosuppressed. Bone marrow and solid organ transplant recipients are particularly at risk of developing serious CMV disease. CMV has the remarkable ability to hide in the body in a dormant or latent form for the life of the host. However, when conditions are right the virus can awaken (ie reactivate) from its latent state, producing new infectious virus and disease. It is in immunosuppressed individuals such as transplant patients that reactivation from latency is of most medical significance, yet the latent phase of infection remains very poorly understood. We recently reported that during latent infection CMV interfered with the expression of a protein which plays a crucial role in our immune system. This protein is called MHC class II and its proper function is essential for our immune system to fight infections. Thus, we postulated that the ability of CMV to successfully hide in a cell in a latent state is at least partially due to its ability to interfere with the cells ability to properly make MHC class II proteins. This project aims to futher define and characterise the functions of latent CMV that enable it to interfere with our immune system. Firstly, we aim to continue with our studies to determine the mechanism by which latent CMV interferes with MHC class II expression. Secondly, we will seek to determine whether latent CMV interferes with any other important components of our immune system. Thirdly, we will seek to identify the precise viral gene that causes the interference with MHC class II expression. Determining the mechanism of immune system regulation and the viral gene(s) responsible for this interference may lead to the design of gene therapies to lessen the clinical impact of CMV disease in transplant recipients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Understanding the role of ongoing viral activity in herpes simplex virus latency
  • 批准号:
    nhmrc : 1126599
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.04万
  • 财政年份:
    2017
  • 负责人:
    A/Pr Allison Abendroth
  • 依托单位:
Mechanisms by which varicella zoster virus and herpes simplex virus control host functions to enhance pathogenesis
  • 批准号:
    nhmrc : 1088005
  • 项目类别:
    Project Grants
  • 资助金额:
    $42.14万
  • 财政年份:
    2015
  • 负责人:
    A/Pr Allison Abendroth
  • 依托单位:
Defining key mechanisms that underpin neuropathogenesis of varicella zoster virus during herpes zoster
  • 批准号:
    nhmrc : 1063744
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.11万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Allison Abendroth
  • 依托单位:
Defining a novel mechanism of control of host functions by human cytomegalovirus that enhances viral pathogenesis
  • 批准号:
    nhmrc : 1063738
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.11万
  • 财政年份:
    2014
  • 负责人:
    A/Pr Allison Abendroth
  • 依托单位:
国内基金
海外基金
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
  • 批准号:
    82371973
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    孙迪
  • 依托单位:
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
  • 批准号:
    82371798
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    叶俊娜
  • 依托单位:
基于FCER1G基因介导免疫反应探讨迟发性聋与认知障碍相关性的机制研究
  • 批准号:
    82371141
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈颖
  • 依托单位:
CD27-CD28-CD8+T细胞调控儿童肝脏移植免疫耐受形成的作用和机制
  • 批准号:
    82371791
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    刘永波
  • 依托单位: